Abstract：Atrial fibrillation is a common type of arrhythmia that can increase the risk of stroke and thrombosis embolism, and lead to heart failure, therefore, early diagnosis and prevention of atrial fibrillation are particularly important.Atrial fibrillation can be diagnosed by the clinical symptoms and signs of patients, and conventional electrocardiogram (ECG) or 24 h dynamic electrocardiogram. With the increase in pacemaker implants, pacemakers provide the conditions for diagnosing and treating atrial fibrillation.This article summarizes the diagnosis of atrial fibrillation by pacemaker, the influence of different types of pacing on atrial fibrillation, and the use of pacemakers to treat atrial fibrillation.
王晓彤. 起搏器植入对房颤的影响及治疗概况[J]. 沈阳医学院学报, 2019, 21(4): 378-382.
WANG Xiaotong. The effect of pacemaker on atrial fibrillation and its treatment. Journal of Shenyang Medical College, 2019, 21(4): 378-382.
Guo Y, Tian Y, Wang H, et al. Prevalence, incidence, and lifetime risk of atrial fibrillation in China:new insights into the global burden of atrial fibrillation[J]. Chest, 2015, 147(1):109-119.
[2]
Kaufman ES, Israel CW, Nair GM, et al.Positive predictive value of device-detected atrial high-rate episodes at different rates and durations:An analysis from ASSERT[J]. Heart Rhythm, 2012, 9(8):1241-1246.
[3]
Dai M, Lu J, Qian DJ, et al.Assessment of left ventricular dyssynchrony and cardiac function in patients with different pacing modes using real-time three-dimensional echocardiography:comparison with tissue Doppler imaging[J]. Exp Ther Med, 2013, 6(5):1213-1219.
Tanaka M, Kanae S, Maki-Oi M, et al.Comparison of the influence of right atrial septal pacing and appendage pacing on an atrial function and atrial fibrillation in the clinical situation[J]. J Atr Fibrillation, 2016, 9(1):1435.
[6]
Sweeney MO, Ellenbogen KA, Casavant D, et al.Multicenter, prospective, randomized safety and efficacy study of a new atrialbased managed ventricular pacing mode(MVP)in dual chamber ICDs[J]. J Cardiovasc Electrophysiol, 2005, 16(8):811-817.
[7]
Healey JS, Toff WD, Lamas GA, et al. Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing:metaanalysis of randomized trials, using individual patient data[J]. Circulation, 2006, 11(4):11-17.
[8]
Brignole M,Auricchio A,Baron-Esquivias G,et al. 2013ESC Guidelines on cardiacpacing and cardiac resynchronization therapy[J]. EurHeart J, 2013, 34(29):2281-2329.
[9]
Das A, Kahali D.Physiological cardiac pacing:current status[J]. Indian Heart J, 2016, 68(4):552-558.
[10]
Da Costa A, Gabriel L, Romeyer-Bouchard C, et al. Focus on right ventricular outflow tract septal pacing[J]. Arch Cardiovasc Dis, 2013, 106(6-7):394-403.
[11]
Sweeney MO, Bank AJ, Nsah E, et al. Minimizing ventricular pacing to reduceatrial fibrillationin sinus-nodedisease[J]. N Engl J Med, 2007, 357(10):1000-1008.
[12]
Cheung JW, Keating RJ, Stein KM, et al. Newly detectedatrial fibrillationfollowing dual chamber pacemaker implantation[J]. J Cardiovasc Electrophysiol, 2006, 17(12):1323-1328.
Lee SH, Park SJ, Kim JS, et al. Mid-termoutcomesin patients implantedwith cardiac resynchronization therapy[J]. J Korean Med Sci, 2014, 29(12):1651-1657.
[16]
Linde C, Gold MR, Abraham WT, et al.Long-term impact of cardiac resynchronization therapy in mild heart failure:5-year results from the resynchronization reverses remodeling in systolic left ventricular dysfunction(REVERSE)study[J]. Eur Heart J, 2013, 34(33):2592-2599.
[17]
Fung JW, Yu CM, Chan JY, et al. Effects of cardiac resynchronizationtherapyon incidenceof atrialfibrillation in patients with poor left ventricular systolic function[J]. Am J Cardiol, 2005, 96(5):728-731.
[18]
Borleffs C, Ypenburg C, van Bommel RJ, et al. Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapy[J]. Heart Rhythm, 2009, 6(3):305-310.
[19]
Fung JW, Yip GW, Zhang Q, et al. Improvement of left atrial function is associated with lower incidence of atrial fibrillationand mortality after cardiac resynchronization therapy[J]. Heart Rhythm, 2008, 5(6):780-786.
[20]
Gasparini M, Steinberg JS, Arshad A, et al. Resumption of sinus rhythm in patients with heart failure and permanentatrial fibrillationundergoingcardiac resynchronizationtherapy:a longitudinal observational study[J]. Eur Heart J, 2010, 31(8):976-983.
[21]
Fernández Lozano I, Mateas FR, Osca J, et al.Comments on the 2013ESC guidelineson cardiac pacing and cardiac resynchronization therapy[J]. Rev Esp Cardiol(Engl Ed), 2014, 67(1):6-14..
[22]
Best PJ,Hayes DL,Stanton MS. The potential usage of dual chamber pacing in patients with implantable cardioverter defibrillators[J]. Pacing Clin Electrophysiol, 1999, 22(1 Pt 1):79-85.
[23]
Sweeney MO, Ellenbogen KA, Tang AS, et al.Atrial pacing or ventricular backup-only pacing in implantable cardioverterdefibrillator patients[J]. Heart Rhythm, 2010, 7(11):1552-1560.
[24]
Brigadeau F, Kouakam C, Klug D, et al. Clinical predictors and prognostic significance of electrical storm in patientswith implantable cardioverter defibrillators[J]. Eur Heart J, 2006, 27(6):700-707.
[25]
Daubert JP, Zareba W, Cannom DS, et al.Inappropriate implantable cardioverter defibrillator shocks in MADIT Ⅱ:frequency, mechanisms, predictors, and survival impact[J]. J Am Coll Cardiol, 2008, 51(14) 1357-1365.
Shurrab M, Healey JS, Haj-Yahia S, et al. Reduction in unnecessary ventricular pacing fails to affect hard clinical outcomes in patients with preserved left ventricular function:a meta-analysis.[J]. Europace, 2017, 19(2):282-288.
Hettrick DA, Euler DE, Pagel PS, et al.Atrial pacinglead locationalters the effects of atrioventricular delay on atrial and ventricular hemodynamics[J]. Pacing Clin Electrophysiol, 2002, 25(6):888-896.
[32]
Das A. Electrocardiographic features:various atrial site pacing[J]. Indian Heart J, 2017, 69(5):675-680.
[33]
Minamiguchi H, Nanto S, Onishi T, et al.Low atrial septal pacing with dual chamber pacemakers reduces atrial fibrillation in sick sinus syndrome[J]. J Cardiol, 2011, 57(2):223-230.
[34]
Zhang L, Jiang H, Wang W, et al.Interatrial septum versus right atrial appendage pacing for prevention of atrial fibrillation:a meta-analysis of randomized controlled trials[J]. Herz, 2018, 43(5):438-446.
[35]
Saksena S, Prakash A, Hill M, et al. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing[J]. J Am Coll Cardiol, 1996, 28(3):687-694.
[36]
Lewicka-Nowak E, Kutarski A, Dabrowska-Kugacka A, et al. A novel method of multisite atrial pacing,incorporating Bachmann's bundle area and coronary sinus ostium, for electrical atrial resynchronization in patients with recurrent atrial fibrillation[J]. Europace, 2007, 9(9):805-811.
[37]
Kli M, Sawuta A, Gajek J.Antiarrhythmic properties of atrial pacing[J]. Adv Clin Exp Med, 2017, 26(2):351-357.
Lewalter T, Yang A, Pfeiffer D, et al. Individualized selection of pacing algorithms for the prevention of recurrent atrial fibrillation:results from the VIP registry[J]. Pacing Clin Electrophysiol, 2006, 29(2):124-134.
[40]
Carlson MD, Ip J, Messenger J, et al. A new pacemakeralgorithmfor the treatment of atrial fibrillation:results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT)[J]. J Am Coll Cardiol, 2003, 42(4):627-633.
[41]
Boriani G, Tukkie R, Manolis AS, et al.Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias:the MINERVA randomized multicentre international trial[J]. Eur Heart J, 2014, 35(35):2352-2362.
[42]
Hohnloser SH, Healey JS, Gold MR, et al.Atrial overdrive pacing to prevent atrial fibrillation:insights from ASSERT[J]. HeartRhythm, 2012, 9(10):1667-1671.
[43]
Lau CP, Tachapong N, Wang CC, et al. Prospective randomized study to assess the efficacy of site and rate of atrial pacing on long-term progression of atrial fibrillation in sick sinus syndrome:septal pacing for atrial fibrillation suppression evaluation (SAFE) Study[J]. Circulation, 2013, 128(7):687-693.
2019, Vol. 21 
